ETNPPL

Chr 4

ethanolamine-phosphate phospho-lyase

Also known as: AGXT2L1

Enables ethanolamine-phosphate phospho-lyase activity. Predicted to act upstream of or within several processes, including cellular response to glucocorticoid stimulus; ceramide phosphoethanolamine catabolic process; and phospholipid transfer to membrane. Predicted to be located in mitochondrial matrix. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…
0
Active trials
16
Pubs (1 yr)
P/LP submissions
P/LP missense
0.74
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.74LOEUF
pLI 0.000
Z-score 2.55
OE 0.45 (0.280.74)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.73Z-score
OE missense 0.71 (0.630.80)
194 obs / 274.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.45 (0.280.74)
00.351.4
Missense OE?0.71 (0.630.80)
00.61.4
Synonymous OE?1.12
01.21.6
LoF obs/exp: 11 / 24.7Missense obs/exp: 194 / 274.6Syn Z: -0.93

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ETNPPL · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →